Su reducción como terapéutica de la obesidad y resistencia a la insulina | 06 MAY 18

El rol de la hiperinsulinemia en la obesidad y la diabetes 2

La hipersecreción de insulina contribuye a la obesidad inducida por la alimentación. Reducir la hiperinsulinemia con la dieta puede prevenir y revertir la obesidad
INDICE:  1. Página 1 | 2. Referencias bibliográficas | 3. Diabetes e intervenciones
Referencias bibliográficas

1. Prentki, M. and Nolan, C.J.(2006) Islet beta cell failure in type 2 diabetes. J. Clin.Invest. 116, 1802–1812

2. De Fronzo, R.A. and Ferrannini, E.(1991)Insulin resistance. A multifaceted síndrome responsable for NIDDM, obesity, hyper tension, dyslipidemia,and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194

3. Czech, M.P.(2017) Insulin action and resistance in obesity and type 2 diabetes. Nat. Med. 23, 804–814

4. Corkey, B.E.(2012) Bantinglecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61, 4–13

5. Erion, K.A. and Corkey,B.E.(2017) Hyperinsulinemia: a cause of obesity? Curr. Obes.Rep. 6, 178–186

6. Mehran, A.E. et al. (2012) Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 16, 723–737

7. Templeman, N.M. et al. (2017) Reduced circulating insulin enhances insulin sensitivity in old mice and extends life span. Cell Rep. 20, 451–463

8. Templeman, N.M. et al. (2015) Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity. Diabetologia 58, 2392–2402

9. Page, M.M. et al. (2017) Reducing insulin via conditional partial gene ablation in adults reverses diet-induced weight gain. FASEB J. 32, 1196–1206

10. Berry, R. et al. (2014) Weighing in on adipocyte precursors. Cell Metab. 19, 8–20

11. Lim, G.E. et al. (2015) 14-3-3 zeta coordinates adipogenesis of visceral fat. Nat. Commun. 6, 7671

12. Templeman, N.M. et al. (2017) A causal role for hyperinsulinemia in obesity. J. Endocrinol. 232, R173–R183

13. Gagnon, A. andSorisky, A.(1998) The effect of glucose concentration on insulin-induced 3T3-L1 adipose cell differentiation. Obes. Res. 6, 157–163

14. Nielsen, T.S. et al. (2014) Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J. Mol. Endocrinol. 52, R199–R222

15. Czech, M.P. et al. (2013) Insulin signaling mechanisms for triacylglycerol storage. Diabetologia 56, 949–964

16. Softic, S. et al. (2016) Lipodystrophy due to adipose tissue- specific insulin receptor knock out results in progressive NAFLD. Diabetes 65, 2187–2200

17. Boucher, J. et al. (2012) Impaired thermogenesis and adipose tissue development in mice withfat-specific disruption of insulin and IGF-1 signalling. Nat. Commun. 3, 902

18. Bluher, M. et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3, 25–38

19. Cristancho, A.G.andLazar,M.A.(2011)Formingfunctionalfat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. CellBiol. 12, 722–734

20. Jones, J.R. et al. (2005) Deletion of PPAR gamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc. Natl.Acad.Sci.U.S.A. 102, 6207– 6212

21. Um, S.H. et al. (2004) Absence of S6K1 protects against age and diet-induced obesity whileenhancing insulin sensitivity. Nature 431, 200–205

22. Carnevalli, L.S. et al. (2010) S6K1 plays a critical role in early adipocyte differentiation. Dev. Cell 18, 763–774

23. Guerra, C. et al. (2001) Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J. Clin.Invest. 108, 1205–1213

24. Wajchenberg, B.L.(2000)Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697–738

25. Skovso, S. et al. (2015) Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes. Int. J.Obes.(Lond.) 39, 1531–1538

26. Demerath, E.W. et al. (2007) Anatomical patternig of visceral adipose tissue: race, sex, and age variation. Obesity (Silver Spring) 15, 2984–2993 27.

Wicksteed, B. et al. (2003) Glucose-induced translational control of proinsulin biosynthesis isproportional to preproinsulin mRNA levels in islet beta-cells but not regulated via a positive feedback of secreted insulin. J. Biol.Chem. 278, 42080–42090

28. Keane, K.and Newsholme,P.(2014) Metabolic regulation of insulin secretion. Vitam. Horm. 95, 1–33

29. Henquin, J.C. and Nenquin,M.(2016) Dynamics and regulation of insulin secretion in pancreatic islets from normaly oungchil- dren. PLoS One 11, e0165961

30. Chen, M. et al. (1985) Pathogenesis of age-related glucose intolerance inman: insulin resistance and decreased beta-cell function. J. Clin.Endocrinol.Metab. 60, 13–20

31. Montanya,E. et al. (2000) Linear correlation between beta-cell mass and body weight throughout the lifes pan in Lewisrats: role of beta-cell hyperplasia and hypertrophy. Diabetes 49,1341–1346

32. Lyon, J. et al. (2016) Research-focused isolation of human islets from donors with and without diabetes at the Alberta Diabetes Institute Islet Core. Endocrinology 157, 560–569

33. Szabat, M. et al. (2016) Reduced insulin production relieves endoplasmic reticulum stress and induces beta cell proliferation. Cell Metab. 23, 179–193

34. Gregg, T. et al. (2016) Pancreatic beta-cells from mice off set age-associated mitochondrial deficiency with reduced KATP channel activity. Diabetes 65, 2700–2710

35. Hamza, S.M. et al. (2017) Chronic insulininfusion induces reversible glucose intolerance in lean rats etameliorates glucose intolerance in obese rats. Biochim. Biophys.Acta 1861, 313–322 36. orita, I. et al. (2017) Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats. Am. J. Physiol. Endocrinol.Metab. 312, E264–E272

37. Furnica, R.M. et al. (2017) A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma. Ann. Endocrinol. (Paris) 79, 30–36

38. Nolan, C.J. et al. (2015) Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes. Diabetes 64, 673–686

39. Czech, M.P.(1985) The nature and regulation of the insulin receptor: structure and function. Annu. Rev.Physiol. 47, 357–381

40. Zick, Y.(2004) Uncoupling insulin signaling by serine/threonine phosphorylation: a molecular basis for insulin resistance. Bio-chem. Soc.Trans. 32, 812–816

41. Boucher, J. et al. (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb.Perspect.Biol. 6, a009191

42. Gray, S.L. et al. (2010) Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling. Endo-crinology 151, 4178–4186

43. D"Souza, A.M. et al. (2016) Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin-deficient Lepob/obmice. Mol. Metab. 5, 1103–1112

44. Odeleye, O.E. et al. (1997) Fasting hyperinsulinemia is a predic tor of increased body weight gain and obesity in Pima Indian children. Diabetes 46, 1341–1345

45. Chen, Y.Y. et al. (2015) Fasting plasma insulin at 5 years of age predicted subsequent weight increase in early childhood over a 5-year period-The Da Qing Children Cohort Study. PLoS One 10, e0127389

46. Arslanian, S.A. et al. (2002) Hyperinsulinemia in African-American children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 51, 3014–3019

47. Satin, L.S. et al. (2015) Pulsatile insulin secretion, impaired glucose tolerance and type 2diabetes. Mol. AspectsMed. 42, 61–77

48. Cavallo-Perin, P. et al. (1993) Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance. Acta Diabetol. 30, 154– 158  49. Weir, G.C. et al. (2001) Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50 (Suppl.1), S154–S159

50. Hatori, M. et al. (2012) Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 15, 848–860 51. Harris,L. et al. (2018) Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and metaanalysis. JBI Database Syst.Rev.Implement.Rep. 16,507–547

52. Shanik, M.H. et al. (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the car torthe horse? Diabetes Care 31 (Suppl. 2),S262–S268 53. Dankner,R. et al. (2009) Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24- year follow-up: a preliminary report. DiabetesCare 32,1464–1466

54. Templeman, N.M. et al. (2016) Hypervariability in circulating insulin, high fat feeding outcomes, and effects of reducing Ins 2 dosage in male Ins1-null mice in a specific pathogen-free facility. PLoS One 11, e0153280  

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024